APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharma and Cetirizine OTC

Cetirizine Hydrochloride (trade names Zirtec, Zyrtec, Reactine) is a second-generation antihistamine used in the treatment of hay fever, allergies, angioedema, and urticaria.[1] It is a major metabolite of hydroxyzine, and a racemic selective H1 receptor antagonist.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Cetirizine Hydrochloride (trade names Zirtec, Zyrtec, Reactine) is a second-generation antihistamine used in the treatment of hay fever, allergies, angioedema, and urticaria.[1] It is a major metabolite of hydroxyzine, and a racemic selective H1 receptor antagonist.

Selected research

Market Structure

Global Pharma and Cetirizine OTC Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025190 pages

Choose your research edition.

Industry ResearchPharma and Cetirizine OTC Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharma and Cetirizine OTC Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Pharma and Cetirizine OTC Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharma and Cetirizine OTC Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharma and Cetirizine OTC Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

Cetirizine Hydrochloride (trade names Zirtec, Zyrtec, Reactine) is a second-generation antihistamine used in the treatment of hay fever, allergies, angioedema, and urticaria.[1] It is a major metabolite of hydroxyzine, and a racemic selective H1 receptor antagonist.

In United States, Pharma and Cetirizine OTC key players include J & J, SANOFI-AVENTIS US LLC, PL DEVELOPMENTS INC, APOTEX, Teva, etc.

This report provides an overview of the global Pharma and Cetirizine OTC market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Pharma and Cetirizine OTC and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharma and Cetirizine OTC sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharma and Cetirizine OTC market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharma and Cetirizine OTC Segment by Company

J & J

SANOFI-AVENTIS US LLC

PL DEVELOPMENTS INC

APOTEX

Teva

MCKESSON CORP

Perrigo

Taro Pharmaceutical

CVS Pharmacy

Major® Pharmaceuticals

Mylan

Amneal

NOVARTIS

Cardinal

Jubilant Life Sciences

Novel Laboratories

Medline

Macleods

Torrent Pharmaceuticals

Micro Labs Limited

Dr. Reddy's Laboratories

Cipla

Aurobindo Pharma

Glenmark

Synthon

Magno-Humphries

Unique Pharmaceutical

ALLEGIANT HEALTH

Silarx Pharmaceuticals

Sun Pharma

UNICHEM LABORATORIES LTD

Pro Doc Limitee

NorthStar Rx LLC

ACETO

Strides Shasun

Pharma and Cetirizine OTC Segment by Type

Tablet

Capsule

Pharma and Cetirizine OTC Segment by Application

Hospital

Clinic

Drug Store

Other

Pharma and Cetirizine OTC Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma and Cetirizine OTC market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharma and Cetirizine OTC and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma and Cetirizine OTC.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharma and Cetirizine OTC market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pharma and Cetirizine OTC manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pharma and Cetirizine OTC in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pharma and Cetirizine OTC in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pharma and Cetirizine OTC Industry Trends Table 2. Pharma and Cetirizine OTC Industry Drivers Table 3. Pharma and Cetirizine OTC Industry Opportunities and Challenges Table 4. Pharma and Cetirizine OTC Industry Restraints Table 5. Global Pharma and Cetirizine OTC Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pharma and Cetirizine OTC Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pharma and Cetirizine OTC Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Pharma and Cetirizine OTC Sales Market Share by Manufacturers Table 9. Global Pharma and Cetirizine OTC Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Pharma and Cetirizine OTC Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pharma and Cetirizine OTC Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pharma and Cetirizine OTC Manufacturers, Product Type & Application Table 13. Global Pharma and Cetirizine OTC Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pharma and Cetirizine OTC by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablet Table 17. Major Manufacturers of Capsule Table 18. Global Pharma and Cetirizine OTC Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Pharma and Cetirizine OTC Sales by Type (2021-2026) & (K Units) Table 20. Global Pharma and Cetirizine OTC Sales by Type (2027-2032) & (K Units) Table 21. Global Pharma and Cetirizine OTC Sales Market Share by Type (2021-2026) Table 22. Global Pharma and Cetirizine OTC Sales Market Share by Type (2027-2032) Table 23. Global Pharma and Cetirizine OTC Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Pharma and Cetirizine OTC Revenue by Type (2021-2026) & (K Units) Table 25. Global Pharma and Cetirizine OTC Revenue by Type (2027-2032) & (K Units) Table 26. Global Pharma and Cetirizine OTC Revenue Market Share by Type (2021-2026) Table 27. Global Pharma and Cetirizine OTC Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Drug Store Table 31. Major Manufacturers of Other Table 32. Global Pharma and Cetirizine OTC Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Pharma and Cetirizine OTC Sales by Application (2021-2026) & (K Units) Table 34. Global Pharma and Cetirizine OTC Sales by Application (2027-2032) & (K Units) Table 35. Global Pharma and Cetirizine OTC Sales Market Share by Application (2021-2026) Table 36. Global Pharma and Cetirizine OTC Sales Market Share by Application (2027-2032) Table 37. Global Pharma and Cetirizine OTC Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Pharma and Cetirizine OTC Revenue by Application (2021-2026) & (K Units) Table 39. Global Pharma and Cetirizine OTC Revenue by Application (2027-2032) & (K Units) Table 40. Global Pharma and Cetirizine OTC Revenue Market Share by Application (2021-2026) Table 41. Global Pharma and Cetirizine OTC Revenue Market Share by Application (2027-2032) Table 42. Global Pharma and Cetirizine OTC Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Pharma and Cetirizine OTC Sales by Region (2021-2026) & (K Units) Table 44. Global Pharma and Cetirizine OTC Sales Market Share by Region (2021-2026) Table 45. Global Pharma and Cetirizine OTC Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Pharma and Cetirizine OTC Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Pharma and Cetirizine OTC Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Pharma and Cetirizine OTC Sales by Country (2021-2026) & (K Units) Table 49. North America Pharma and Cetirizine OTC Sales by Country (2027-2032) & (K Units) Table 50. Europe Pharma and Cetirizine OTC Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Pharma and Cetirizine OTC Sales by Country (2021-2026) & (K Units) Table 52. Europe Pharma and Cetirizine OTC Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Pharma and Cetirizine OTC Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Pharma and Cetirizine OTC Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Pharma and Cetirizine OTC Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Pharma and Cetirizine OTC Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Pharma and Cetirizine OTC Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Pharma and Cetirizine OTC Sales by Country (2027-2032) & (K Units) Table 59. Global Pharma and Cetirizine OTC Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Pharma and Cetirizine OTC Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Pharma and Cetirizine OTC Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Pharma and Cetirizine OTC Revenue Market Share by Region (2021-2026) Table 63. Global Pharma and Cetirizine OTC Revenue Market Share by Region (2027-2032) Table 64. J & J Company Information Table 65. J & J Business Overview Table 66. J & J Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. J & J Pharma and Cetirizine OTC Product Portfolio Table 68. J & J Recent Development Table 69. SANOFI-AVENTIS US LLC Company Information Table 70. SANOFI-AVENTIS US LLC Business Overview Table 71. SANOFI-AVENTIS US LLC Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. SANOFI-AVENTIS US LLC Pharma and Cetirizine OTC Product Portfolio Table 73. SANOFI-AVENTIS US LLC Recent Development Table 74. PL DEVELOPMENTS INC Company Information Table 75. PL DEVELOPMENTS INC Business Overview Table 76. PL DEVELOPMENTS INC Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. PL DEVELOPMENTS INC Pharma and Cetirizine OTC Product Portfolio Table 78. PL DEVELOPMENTS INC Recent Development Table 79. APOTEX Company Information Table 80. APOTEX Business Overview Table 81. APOTEX Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. APOTEX Pharma and Cetirizine OTC Product Portfolio Table 83. APOTEX Recent Development Table 84. Teva Company Information Table 85. Teva Business Overview Table 86. Teva Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Teva Pharma and Cetirizine OTC Product Portfolio Table 88. Teva Recent Development Table 89. MCKESSON CORP Company Information Table 90. MCKESSON CORP Business Overview Table 91. MCKESSON CORP Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. MCKESSON CORP Pharma and Cetirizine OTC Product Portfolio Table 93. MCKESSON CORP Recent Development Table 94. Perrigo Company Information Table 95. Perrigo Business Overview Table 96. Perrigo Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Perrigo Pharma and Cetirizine OTC Product Portfolio Table 98. Perrigo Recent Development Table 99. Taro Pharmaceutical Company Information Table 100. Taro Pharmaceutical Business Overview Table 101. Taro Pharmaceutical Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Taro Pharmaceutical Pharma and Cetirizine OTC Product Portfolio Table 103. Taro Pharmaceutical Recent Development Table 104. CVS Pharmacy Company Information Table 105. CVS Pharmacy Business Overview Table 106. CVS Pharmacy Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. CVS Pharmacy Pharma and Cetirizine OTC Product Portfolio Table 108. CVS Pharmacy Recent Development Table 109. Major® Pharmaceuticals Company Information Table 110. Major® Pharmaceuticals Business Overview Table 111. Major® Pharmaceuticals Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Major® Pharmaceuticals Pharma and Cetirizine OTC Product Portfolio Table 113. Major® Pharmaceuticals Recent Development Table 114. Mylan Company Information Table 115. Mylan Business Overview Table 116. Mylan Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Mylan Pharma and Cetirizine OTC Product Portfolio Table 118. Mylan Recent Development Table 119. Amneal Company Information Table 120. Amneal Business Overview Table 121. Amneal Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Amneal Pharma and Cetirizine OTC Product Portfolio Table 123. Amneal Recent Development Table 124. NOVARTIS Company Information Table 125. NOVARTIS Business Overview Table 126. NOVARTIS Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. NOVARTIS Pharma and Cetirizine OTC Product Portfolio Table 128. NOVARTIS Recent Development Table 129. Cardinal Company Information Table 130. Cardinal Business Overview Table 131. Cardinal Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Cardinal Pharma and Cetirizine OTC Product Portfolio Table 133. Cardinal Recent Development Table 134. Jubilant Life Sciences Company Information Table 135. Jubilant Life Sciences Business Overview Table 136. Jubilant Life Sciences Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Jubilant Life Sciences Pharma and Cetirizine OTC Product Portfolio Table 138. Jubilant Life Sciences Recent Development Table 139. Novel Laboratories Company Information Table 140. Novel Laboratories Business Overview Table 141. Novel Laboratories Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Novel Laboratories Pharma and Cetirizine OTC Product Portfolio Table 143. Novel Laboratories Recent Development Table 144. Medline Company Information Table 145. Medline Business Overview Table 146. Medline Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Medline Pharma and Cetirizine OTC Product Portfolio Table 148. Medline Recent Development Table 149. Macleods Company Information Table 150. Macleods Business Overview Table 151. Macleods Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. Macleods Pharma and Cetirizine OTC Product Portfolio Table 153. Macleods Recent Development Table 154. Torrent Pharmaceuticals Company Information Table 155. Torrent Pharmaceuticals Business Overview Table 156. Torrent Pharmaceuticals Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 157. Torrent Pharmaceuticals Pharma and Cetirizine OTC Product Portfolio Table 158. Torrent Pharmaceuticals Recent Development Table 159. Micro Labs Limited Company Information Table 160. Micro Labs Limited Business Overview Table 161. Micro Labs Limited Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 162. Micro Labs Limited Pharma and Cetirizine OTC Product Portfolio Table 163. Micro Labs Limited Recent Development Table 164. Dr. Reddy's Laboratories Company Information Table 165. Dr. Reddy's Laboratories Business Overview Table 166. Dr. Reddy's Laboratories Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 167. Dr. Reddy's Laboratories Pharma and Cetirizine OTC Product Portfolio Table 168. Dr. Reddy's Laboratories Recent Development Table 169. Cipla Company Information Table 170. Cipla Business Overview Table 171. Cipla Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 172. Cipla Pharma and Cetirizine OTC Product Portfolio Table 173. Cipla Recent Development Table 174. Aurobindo Pharma Company Information Table 175. Aurobindo Pharma Business Overview Table 176. Aurobindo Pharma Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 177. Aurobindo Pharma Pharma and Cetirizine OTC Product Portfolio Table 178. Aurobindo Pharma Recent Development Table 179. Glenmark Company Information Table 180. Glenmark Business Overview Table 181. Glenmark Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 182. Glenmark Pharma and Cetirizine OTC Product Portfolio Table 183. Glenmark Recent Development Table 184. Synthon Company Information Table 185. Synthon Business Overview Table 186. Synthon Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 187. Synthon Pharma and Cetirizine OTC Product Portfolio Table 188. Synthon Recent Development Table 189. Magno-Humphries Company Information Table 190. Magno-Humphries Business Overview Table 191. Magno-Humphries Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 192. Magno-Humphries Pharma and Cetirizine OTC Product Portfolio Table 193. Magno-Humphries Recent Development Table 194. Unique Pharmaceutical Company Information Table 195. Unique Pharmaceutical Business Overview Table 196. Unique Pharmaceutical Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 197. Unique Pharmaceutical Pharma and Cetirizine OTC Product Portfolio Table 198. Unique Pharmaceutical Recent Development Table 199. ALLEGIANT HEALTH Company Information Table 200. ALLEGIANT HEALTH Business Overview Table 201. ALLEGIANT HEALTH Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 202. ALLEGIANT HEALTH Pharma and Cetirizine OTC Product Portfolio Table 203. ALLEGIANT HEALTH Recent Development Table 204. Silarx Pharmaceuticals Company Information Table 205. Silarx Pharmaceuticals Business Overview Table 206. Silarx Pharmaceuticals Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 207. Silarx Pharmaceuticals Pharma and Cetirizine OTC Product Portfolio Table 208. Silarx Pharmaceuticals Recent Development Table 209. Sun Pharma Company Information Table 210. Sun Pharma Business Overview Table 211. Sun Pharma Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 212. Sun Pharma Pharma and Cetirizine OTC Product Portfolio Table 213. Sun Pharma Recent Development Table 214. UNICHEM LABORATORIES LTD Company Information Table 215. UNICHEM LABORATORIES LTD Business Overview Table 216. UNICHEM LABORATORIES LTD Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 217. UNICHEM LABORATORIES LTD Pharma and Cetirizine OTC Product Portfolio Table 218. UNICHEM LABORATORIES LTD Recent Development Table 219. Pro Doc Limitee Company Information Table 220. Pro Doc Limitee Business Overview Table 221. Pro Doc Limitee Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 222. Pro Doc Limitee Pharma and Cetirizine OTC Product Portfolio Table 223. Pro Doc Limitee Recent Development Table 224. NorthStar Rx LLC Company Information Table 225. NorthStar Rx LLC Business Overview Table 226. NorthStar Rx LLC Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 227. NorthStar Rx LLC Pharma and Cetirizine OTC Product Portfolio Table 228. NorthStar Rx LLC Recent Development Table 229. ACETO Company Information Table 230. ACETO Business Overview Table 231. ACETO Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 232. ACETO Pharma and Cetirizine OTC Product Portfolio Table 233. ACETO Recent Development Table 234. Strides Shasun Company Information Table 235. Strides Shasun Business Overview Table 236. Strides Shasun Pharma and Cetirizine OTC Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 237. Strides Shasun Pharma and Cetirizine OTC Product Portfolio Table 238. Strides Shasun Recent Development Table 239. Key Raw Materials Table 240. Raw Materials Key Suppliers Table 241. Pharma and Cetirizine OTC Distributors List Table 242. Pharma and Cetirizine OTC Customers List Table 243. Research Programs/Design for This Report Table 244. Authors List of This Report Table 245. Secondary Sources Table 246. Primary Sources List of Figures Figure 1. Pharma and Cetirizine OTC Product Image Figure 2. Global Pharma and Cetirizine OTC Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharma and Cetirizine OTC Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharma and Cetirizine OTC Sales (2021-2032) & (K Units) Figure 5. Global Pharma and Cetirizine OTC Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pharma and Cetirizine OTC Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablet Image Figure 9. Capsule Image Figure 10. Global Pharma and Cetirizine OTC Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Pharma and Cetirizine OTC Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Pharma and Cetirizine OTC Sales Market Share by Type (2021-2032) Figure 13. Global Pharma and Cetirizine OTC Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Pharma and Cetirizine OTC Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Pharma and Cetirizine OTC Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Drug Store Image Figure 19. Other Image Figure 20. Global Pharma and Cetirizine OTC Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Pharma and Cetirizine OTC Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Pharma and Cetirizine OTC Sales Market Share by Application (2021-2032) Figure 23. Global Pharma and Cetirizine OTC Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Pharma and Cetirizine OTC Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Pharma and Cetirizine OTC Revenue Market Share by Application (2021-2032) Figure 26. North America Pharma and Cetirizine OTC Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Pharma and Cetirizine OTC Sales Market Share by Country (2021-2032) Figure 28. U.S. Pharma and Cetirizine OTC Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Pharma and Cetirizine OTC Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Pharma and Cetirizine OTC Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Pharma and Cetirizine OTC Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Pharma and Cetirizine OTC Sales Market Share by Country (2021-2032) Figure 33. Germany Pharma and Cetirizine OTC Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Pharma and Cetirizine OTC Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Pharma and Cetirizine OTC Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Pharma and Cetirizine OTC Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Pharma and Cetirizine OTC Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Pharma and Cetirizine OTC Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Pharma and Cetirizine OTC Sales Market Share by Country (2021-2032) Figure 40. China Pharma and Cetirizine OTC Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Pharma and Cetirizine OTC Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Pharma and Cetirizine OTC Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Pharma and Cetirizine OTC Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Pharma and Cetirizine OTC Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Pharma and Cetirizine OTC Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Pharma and Cetirizine OTC Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Pharma and Cetirizine OTC Sales Market Share by Country (2021-2032) Figure 48. Brazil Pharma and Cetirizine OTC Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Pharma and Cetirizine OTC Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Pharma and Cetirizine OTC Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Pharma and Cetirizine OTC Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Pharma and Cetirizine OTC Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Pharma and Cetirizine OTC Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Pharma and Cetirizine OTC Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Pharma and Cetirizine OTC Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Pharma and Cetirizine OTC Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Pharma and Cetirizine OTC Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Pharma and Cetirizine OTC Revenue (2021-2032) & (US$ Million) Figure 59. North America Pharma and Cetirizine OTC Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Pharma and Cetirizine OTC Revenue (2021-2032) & (US$ Million) Figure 61. Europe Pharma and Cetirizine OTC Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Pharma and Cetirizine OTC Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Pharma and Cetirizine OTC Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Pharma and Cetirizine OTC Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Pharma and Cetirizine OTC Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Pharma and Cetirizine OTC Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Pharma and Cetirizine OTC Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Capsule
Applications
  • Hospital
  • Clinic
  • Drug Store
  • Other
Companies covered
  • J & J
  • SANOFI-AVENTIS US LLC
  • PL DEVELOPMENTS INC
  • APOTEX
  • Teva
  • MCKESSON CORP
  • Perrigo
  • Taro Pharmaceutical
  • CVS Pharmacy
  • Major® Pharmaceuticals
  • Mylan
  • Amneal
  • NOVARTIS
  • Cardinal
  • Jubilant Life Sciences
  • Novel Laboratories
  • Medline
  • Macleods
  • Torrent Pharmaceuticals
  • Micro Labs Limited
  • Dr. Reddy's Laboratories
  • Cipla
  • Aurobindo Pharma
  • Glenmark
  • Synthon
  • Magno-Humphries
  • Unique Pharmaceutical
  • ALLEGIANT HEALTH
  • Silarx Pharmaceuticals
  • Sun Pharma
  • UNICHEM LABORATORIES LTD
  • Pro Doc Limitee
  • NorthStar Rx LLC
  • ACETO
  • Strides Shasun

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharma and Cetirizine OTC Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharma and Cetirizine OTC Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pharma and Cetirizine OTC Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pharma and Cetirizine OTC Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pharma and Cetirizine OTC Market Dynamics
  1. 2.1 Pharma and Cetirizine OTC Industry Trends
  2. 2.2 Pharma and Cetirizine OTC Industry Drivers
  3. 2.3 Pharma and Cetirizine OTC Industry Opportunities and Challenges
  4. 2.4 Pharma and Cetirizine OTC Industry Restraints
3 Pharma and Cetirizine OTC Market by Manufacturers
  1. 3.1 Global Pharma and Cetirizine OTC Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pharma and Cetirizine OTC Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pharma and Cetirizine OTC Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pharma and Cetirizine OTC Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pharma and Cetirizine OTC Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pharma and Cetirizine OTC Manufacturers, Product Type & Application
  7. 3.7 Global Pharma and Cetirizine OTC Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pharma and Cetirizine OTC Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pharma and Cetirizine OTC Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pharma and Cetirizine OTC Tier 1, Tier 2, and Tier 3
4 Pharma and Cetirizine OTC Market by Type
  1. 4.1 Pharma and Cetirizine OTC Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Capsule
  4. 4.2 Global Pharma and Cetirizine OTC Sales by Type
  5. 4.2.1 Global Pharma and Cetirizine OTC Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pharma and Cetirizine OTC Sales by Type (2021-2032)
  7. 4.2.3 Global Pharma and Cetirizine OTC Sales Market Share by Type (2021-2032)
  8. 4.3 Global Pharma and Cetirizine OTC Revenue by Type
  9. 4.3.1 Global Pharma and Cetirizine OTC Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pharma and Cetirizine OTC Revenue by Type (2021-2032)
  11. 4.3.3 Global Pharma and Cetirizine OTC Revenue Market Share by Type (2021-2032)
5 Pharma and Cetirizine OTC Market by Application
  1. 5.1 Pharma and Cetirizine OTC Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Drug Store
  5. 5.1.4 Other
  6. 5.2 Global Pharma and Cetirizine OTC Sales by Application
  7. 5.2.1 Global Pharma and Cetirizine OTC Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Pharma and Cetirizine OTC Sales by Application (2021-2032)
  9. 5.2.3 Global Pharma and Cetirizine OTC Sales Market Share by Application (2021-2032)
  10. 5.3 Global Pharma and Cetirizine OTC Revenue by Application
  11. 5.3.1 Global Pharma and Cetirizine OTC Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Pharma and Cetirizine OTC Revenue by Application (2021-2032)
  13. 5.3.3 Global Pharma and Cetirizine OTC Revenue Market Share by Application (2021-2032)
6 Global Pharma and Cetirizine OTC Sales by Region
  1. 6.1 Global Pharma and Cetirizine OTC Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharma and Cetirizine OTC Sales by Region (2021-2032)
  3. 6.2.1 Global Pharma and Cetirizine OTC Sales by Region (2021-2026)
  4. 6.2.2 Global Pharma and Cetirizine OTC Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharma and Cetirizine OTC Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pharma and Cetirizine OTC Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pharma and Cetirizine OTC Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pharma and Cetirizine OTC Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pharma and Cetirizine OTC Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pharma and Cetirizine OTC Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pharma and Cetirizine OTC Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pharma and Cetirizine OTC Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pharma and Cetirizine OTC Revenue by Region
  1. 7.1 Global Pharma and Cetirizine OTC Revenue by Region
  2. 7.1.1 Global Pharma and Cetirizine OTC Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pharma and Cetirizine OTC Revenue by Region (2021-2026)
  4. 7.1.3 Global Pharma and Cetirizine OTC Revenue by Region (2027-2032)
  5. 7.1.4 Global Pharma and Cetirizine OTC Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pharma and Cetirizine OTC Revenue (2021-2032)
  8. 7.2.2 North America Pharma and Cetirizine OTC Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pharma and Cetirizine OTC Revenue (2021-2032)
  11. 7.3.2 Europe Pharma and Cetirizine OTC Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pharma and Cetirizine OTC Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pharma and Cetirizine OTC Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pharma and Cetirizine OTC Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pharma and Cetirizine OTC Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 J & J
  2. 8.1.1 J & J Company Information
  3. 8.1.2 J & J Business Overview
  4. 8.1.3 J & J Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 J & J Pharma and Cetirizine OTC Product Portfolio
  6. 8.1.5 J & J Recent Developments
  7. 8.2 SANOFI-AVENTIS US LLC
  8. 8.2.1 SANOFI-AVENTIS US LLC Company Information
  9. 8.2.2 SANOFI-AVENTIS US LLC Business Overview
  10. 8.2.3 SANOFI-AVENTIS US LLC Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 SANOFI-AVENTIS US LLC Pharma and Cetirizine OTC Product Portfolio
  12. 8.2.5 SANOFI-AVENTIS US LLC Recent Developments
  13. 8.3 PL DEVELOPMENTS INC
  14. 8.3.1 PL DEVELOPMENTS INC Company Information
  15. 8.3.2 PL DEVELOPMENTS INC Business Overview
  16. 8.3.3 PL DEVELOPMENTS INC Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 PL DEVELOPMENTS INC Pharma and Cetirizine OTC Product Portfolio
  18. 8.3.5 PL DEVELOPMENTS INC Recent Developments
  19. 8.4 APOTEX
  20. 8.4.1 APOTEX Company Information
  21. 8.4.2 APOTEX Business Overview
  22. 8.4.3 APOTEX Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 APOTEX Pharma and Cetirizine OTC Product Portfolio
  24. 8.4.5 APOTEX Recent Developments
  25. 8.5 Teva
  26. 8.5.1 Teva Company Information
  27. 8.5.2 Teva Business Overview
  28. 8.5.3 Teva Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Teva Pharma and Cetirizine OTC Product Portfolio
  30. 8.5.5 Teva Recent Developments
  31. 8.6 MCKESSON CORP
  32. 8.6.1 MCKESSON CORP Company Information
  33. 8.6.2 MCKESSON CORP Business Overview
  34. 8.6.3 MCKESSON CORP Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 MCKESSON CORP Pharma and Cetirizine OTC Product Portfolio
  36. 8.6.5 MCKESSON CORP Recent Developments
  37. 8.7 Perrigo
  38. 8.7.1 Perrigo Company Information
  39. 8.7.2 Perrigo Business Overview
  40. 8.7.3 Perrigo Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Perrigo Pharma and Cetirizine OTC Product Portfolio
  42. 8.7.5 Perrigo Recent Developments
  43. 8.8 Taro Pharmaceutical
  44. 8.8.1 Taro Pharmaceutical Company Information
  45. 8.8.2 Taro Pharmaceutical Business Overview
  46. 8.8.3 Taro Pharmaceutical Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Taro Pharmaceutical Pharma and Cetirizine OTC Product Portfolio
  48. 8.8.5 Taro Pharmaceutical Recent Developments
  49. 8.9 CVS Pharmacy
  50. 8.9.1 CVS Pharmacy Company Information
  51. 8.9.2 CVS Pharmacy Business Overview
  52. 8.9.3 CVS Pharmacy Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 CVS Pharmacy Pharma and Cetirizine OTC Product Portfolio
  54. 8.9.5 CVS Pharmacy Recent Developments
  55. 8.10 Major® Pharmaceuticals
  56. 8.10.1 Major® Pharmaceuticals Company Information
  57. 8.10.2 Major® Pharmaceuticals Business Overview
  58. 8.10.3 Major® Pharmaceuticals Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Major® Pharmaceuticals Pharma and Cetirizine OTC Product Portfolio
  60. 8.10.5 Major® Pharmaceuticals Recent Developments
  61. 8.11 Mylan
  62. 8.11.1 Mylan Company Information
  63. 8.11.2 Mylan Business Overview
  64. 8.11.3 Mylan Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Mylan Pharma and Cetirizine OTC Product Portfolio
  66. 8.11.5 Mylan Recent Developments
  67. 8.12 Amneal
  68. 8.12.1 Amneal Company Information
  69. 8.12.2 Amneal Business Overview
  70. 8.12.3 Amneal Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Amneal Pharma and Cetirizine OTC Product Portfolio
  72. 8.12.5 Amneal Recent Developments
  73. 8.13 NOVARTIS
  74. 8.13.1 NOVARTIS Company Information
  75. 8.13.2 NOVARTIS Business Overview
  76. 8.13.3 NOVARTIS Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 NOVARTIS Pharma and Cetirizine OTC Product Portfolio
  78. 8.13.5 NOVARTIS Recent Developments
  79. 8.14 Cardinal
  80. 8.14.1 Cardinal Company Information
  81. 8.14.2 Cardinal Business Overview
  82. 8.14.3 Cardinal Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Cardinal Pharma and Cetirizine OTC Product Portfolio
  84. 8.14.5 Cardinal Recent Developments
  85. 8.15 Jubilant Life Sciences
  86. 8.15.1 Jubilant Life Sciences Company Information
  87. 8.15.2 Jubilant Life Sciences Business Overview
  88. 8.15.3 Jubilant Life Sciences Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Jubilant Life Sciences Pharma and Cetirizine OTC Product Portfolio
  90. 8.15.5 Jubilant Life Sciences Recent Developments
  91. 8.16 Novel Laboratories
  92. 8.16.1 Novel Laboratories Company Information
  93. 8.16.2 Novel Laboratories Business Overview
  94. 8.16.3 Novel Laboratories Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Novel Laboratories Pharma and Cetirizine OTC Product Portfolio
  96. 8.16.5 Novel Laboratories Recent Developments
  97. 8.17 Medline
  98. 8.17.1 Medline Company Information
  99. 8.17.2 Medline Business Overview
  100. 8.17.3 Medline Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Medline Pharma and Cetirizine OTC Product Portfolio
  102. 8.17.5 Medline Recent Developments
  103. 8.18 Macleods
  104. 8.18.1 Macleods Company Information
  105. 8.18.2 Macleods Business Overview
  106. 8.18.3 Macleods Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Macleods Pharma and Cetirizine OTC Product Portfolio
  108. 8.18.5 Macleods Recent Developments
  109. 8.19 Torrent Pharmaceuticals
  110. 8.19.1 Torrent Pharmaceuticals Company Information
  111. 8.19.2 Torrent Pharmaceuticals Business Overview
  112. 8.19.3 Torrent Pharmaceuticals Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Torrent Pharmaceuticals Pharma and Cetirizine OTC Product Portfolio
  114. 8.19.5 Torrent Pharmaceuticals Recent Developments
  115. 8.20 Micro Labs Limited
  116. 8.20.1 Micro Labs Limited Company Information
  117. 8.20.2 Micro Labs Limited Business Overview
  118. 8.20.3 Micro Labs Limited Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Micro Labs Limited Pharma and Cetirizine OTC Product Portfolio
  120. 8.20.5 Micro Labs Limited Recent Developments
  121. 8.21 Dr. Reddy's Laboratories
  122. 8.21.1 Dr. Reddy's Laboratories Company Information
  123. 8.21.2 Dr. Reddy's Laboratories Business Overview
  124. 8.21.3 Dr. Reddy's Laboratories Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Dr. Reddy's Laboratories Pharma and Cetirizine OTC Product Portfolio
  126. 8.21.5 Dr. Reddy's Laboratories Recent Developments
  127. 8.22 Cipla
  128. 8.22.1 Cipla Company Information
  129. 8.22.2 Cipla Business Overview
  130. 8.22.3 Cipla Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Cipla Pharma and Cetirizine OTC Product Portfolio
  132. 8.22.5 Cipla Recent Developments
  133. 8.23 Aurobindo Pharma
  134. 8.23.1 Aurobindo Pharma Company Information
  135. 8.23.2 Aurobindo Pharma Business Overview
  136. 8.23.3 Aurobindo Pharma Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Aurobindo Pharma Pharma and Cetirizine OTC Product Portfolio
  138. 8.23.5 Aurobindo Pharma Recent Developments
  139. 8.24 Glenmark
  140. 8.24.1 Glenmark Company Information
  141. 8.24.2 Glenmark Business Overview
  142. 8.24.3 Glenmark Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Glenmark Pharma and Cetirizine OTC Product Portfolio
  144. 8.24.5 Glenmark Recent Developments
  145. 8.25 Synthon
  146. 8.25.1 Synthon Company Information
  147. 8.25.2 Synthon Business Overview
  148. 8.25.3 Synthon Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Synthon Pharma and Cetirizine OTC Product Portfolio
  150. 8.25.5 Synthon Recent Developments
  151. 8.26 Magno-Humphries
  152. 8.26.1 Magno-Humphries Company Information
  153. 8.26.2 Magno-Humphries Business Overview
  154. 8.26.3 Magno-Humphries Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Magno-Humphries Pharma and Cetirizine OTC Product Portfolio
  156. 8.26.5 Magno-Humphries Recent Developments
  157. 8.27 Unique Pharmaceutical
  158. 8.27.1 Unique Pharmaceutical Company Information
  159. 8.27.2 Unique Pharmaceutical Business Overview
  160. 8.27.3 Unique Pharmaceutical Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Unique Pharmaceutical Pharma and Cetirizine OTC Product Portfolio
  162. 8.27.5 Unique Pharmaceutical Recent Developments
  163. 8.28 ALLEGIANT HEALTH
  164. 8.28.1 ALLEGIANT HEALTH Company Information
  165. 8.28.2 ALLEGIANT HEALTH Business Overview
  166. 8.28.3 ALLEGIANT HEALTH Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  167. 8.28.4 ALLEGIANT HEALTH Pharma and Cetirizine OTC Product Portfolio
  168. 8.28.5 ALLEGIANT HEALTH Recent Developments
  169. 8.29 Silarx Pharmaceuticals
  170. 8.29.1 Silarx Pharmaceuticals Company Information
  171. 8.29.2 Silarx Pharmaceuticals Business Overview
  172. 8.29.3 Silarx Pharmaceuticals Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  173. 8.29.4 Silarx Pharmaceuticals Pharma and Cetirizine OTC Product Portfolio
  174. 8.29.5 Silarx Pharmaceuticals Recent Developments
  175. 8.30 Sun Pharma
  176. 8.30.1 Sun Pharma Company Information
  177. 8.30.2 Sun Pharma Business Overview
  178. 8.30.3 Sun Pharma Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  179. 8.30.4 Sun Pharma Pharma and Cetirizine OTC Product Portfolio
  180. 8.30.5 Sun Pharma Recent Developments
  181. 8.31 UNICHEM LABORATORIES LTD
  182. 8.31.1 UNICHEM LABORATORIES LTD Company Information
  183. 8.31.2 UNICHEM LABORATORIES LTD Business Overview
  184. 8.31.3 UNICHEM LABORATORIES LTD Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  185. 8.31.4 UNICHEM LABORATORIES LTD Pharma and Cetirizine OTC Product Portfolio
  186. 8.31.5 UNICHEM LABORATORIES LTD Recent Developments
  187. 8.32 Pro Doc Limitee
  188. 8.32.1 Pro Doc Limitee Company Information
  189. 8.32.2 Pro Doc Limitee Business Overview
  190. 8.32.3 Pro Doc Limitee Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  191. 8.32.4 Pro Doc Limitee Pharma and Cetirizine OTC Product Portfolio
  192. 8.32.5 Pro Doc Limitee Recent Developments
  193. 8.33 NorthStar Rx LLC
  194. 8.33.1 NorthStar Rx LLC Company Information
  195. 8.33.2 NorthStar Rx LLC Business Overview
  196. 8.33.3 NorthStar Rx LLC Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  197. 8.33.4 NorthStar Rx LLC Pharma and Cetirizine OTC Product Portfolio
  198. 8.33.5 NorthStar Rx LLC Recent Developments
  199. 8.34 ACETO
  200. 8.34.1 ACETO Company Information
  201. 8.34.2 ACETO Business Overview
  202. 8.34.3 ACETO Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  203. 8.34.4 ACETO Pharma and Cetirizine OTC Product Portfolio
  204. 8.34.5 ACETO Recent Developments
  205. 8.35 Strides Shasun
  206. 8.35.1 Strides Shasun Company Information
  207. 8.35.2 Strides Shasun Business Overview
  208. 8.35.3 Strides Shasun Pharma and Cetirizine OTC Sales, Price, Revenue and Gross Margin (2021-2026)
  209. 8.35.4 Strides Shasun Pharma and Cetirizine OTC Product Portfolio
  210. 8.35.5 Strides Shasun Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pharma and Cetirizine OTC Value Chain Analysis
  2. 9.1.1 Pharma and Cetirizine OTC Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pharma and Cetirizine OTC Production Mode & Process
  6. 9.2 Pharma and Cetirizine OTC Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pharma and Cetirizine OTC Distributors
  9. 9.2.3 Pharma and Cetirizine OTC Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst